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BACKGROUND: The role of coagulase-negative staphylo-
cocci (CNS) in bacteremias continues to be controversial. Until the
1970s, CNS were mostly recognized as contaminants, being part of
the cutaneous flora. Since then, several studies have reported
increasing incidence and severity of infections due to CNS.
PURPOSE: To review the literature concerning the epi-
demiology of CNS bacteremia in the United States and Europe
with reference to the multiple definitions of infection versus conta-
mination, considering the effect of potential biases influencing the
validity of the reported results.
METHODS: Literature search of the MEDLINE database
from January 1980 to February 1998. Studies with fewer than 500
episodes of bloodstream infections or fewer than 100 episodes of
CNS bacteremia were not included in the pooled analysis.
RESULTS: (1) CNS remain the most frequent contami-
nants (58%-83% of positive blood cultures); (2) the proportion of all
bloodstream infections caused by CNS is increasing (R=.51); (3)
the overall incidence of true CNS bacteremia is increasing (R=.54,
P=.0014); (4) comparing the United States to Europe, there is an
increasing trend in the incidence of nosocomial bacteremia due to
CNS in the United States (R=.82, P=.0006), but no trend is seen in
European studies; (5) the mortality associated with true CNS bac-
teremia varies between 4.9% and 28%.
DISCUSSION: This review confirms the increasing impor-
tance of CNS bacteremias, measured both as a proportion and as
an incidence of bloodstream infections. The contributions of sev-
eral possible explanations for the incidence increase and the dif-
ference between the United States and Europe need further evalu-
ation: (1) increased recognition and awareness of CNS infections
among clinicians; (2) a gradual change in the definition of true bac-
teremia from an obligatory two positive blood cultures to one pos-
itive blood culture associated with a clinical picture compatible
with infection; (3) a change in blood culture practices and tech-
niques; (4) an increase in the numbers of blood cultures per-
formed, which is reported both in the United States and in Europe;
(5) a shift toward more elderly patients with increasingly severe
underlying illnesses; and (6) increasing use of intravascular
devices.
CONCLUSIONS: The apparent trend of increasing CNS
bacteremia seems to be valid. Whether there is a real difference
between the United States and Europe concerning the increase of
CNS bacteremia is difficult to establish due to the large number of
confounding factors. Few studies take into account the number of
blood cultures performed or the use of intravascular devices to
adjust for the observed trends. Further on-site surveillance studies
are needed to investigate the phenomenon more extensively
(Infect Control Hosp Epidemiol 1998;19:581-589).
The role and importance of coagulase-negative
staphylococci (CNS) in bloodstream infections (BSIs) con-
tinues to be controversial. They were first described as
pathogens in the 1950s, in the context of cardiovascular
surgery, as techniques for implantation of prosthetic
devices were developed.1 The reporting of CNS was very
low until the 1970s, as they were almost exclusively regard-
ed as contaminants arising from the cutaneous flora.2 Since
then, several studies have reported trends of increasing
incidence and severity of CNS bacteremia both in the Unit-
ed States 3-6 and in Europe.7-11
It is a well-established observation that CNS bac-
teremias are associated with the use of indwelling devices
such as central venous, peripheral venous, or hemodialysis
catheters and prosthetic material.12,13 Two properties of
CNS may explain this: the ability to adhere to foreign bod-
ies and artificial surfaces due to adhesins, and the produc-
tion of extracellular glycocalyx (slime).12,13 
The purpose of this article is to review the literature
concerning the epidemiology of CNS bacteremia in the
United States and in Europe with reference to the multiple
definitions of infection versus contamination and the effect
of potential biases on the validity of the reported results.
METHODS
Data Sources
From the Infection Control Program, the University of Geneva Hospitals, Geneva, Switzerland.
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We searched the MEDLINE database from January
1980 to February 1998 using Knowledge finder (Aries Sys-
tem Corp, North Andover, MA). The following key words
were used: coagulase-negative staphylococci, Staphylococ-
cus epidermidis, staphylococci, epidemiology, bloodstream
infection, bacteremia, sepsis, and septicemia. Frequently
cited articles also were identified.
Study Selection
This literature review generally concentrates on
large tertiary-care centers, but studies from community
hospitals, intensive-care units (ICUs), high-risk nurseries,
and wards with immunosuppressed patients also were con-
sidered to allow for a cross-sectional analysis. We excluded
studies with fewer than 500 episodes of BSI or fewer than
100 episodes of CNS bacteremia. Articles written in Eng-
lish, French, or German were retained for analysis.
Data Extraction
We abstracted data from the studies concerning the
description of the population, definitions of bacteremia and
nosocomial infection, and the incidence of community- and
hospital-acquired CNS bacteremia per 1,000 admissions. We
also calculated the percentage of all BSI episodes due to CNS.
Contamination was calculated both as a proportion of all
CNS-positive blood cultures and as a proportion of all positive
TABLE 1
STUDIES RETAINED FOR ANALYSIS OF TRENDED ESTIMATES, MEDLINE SEARCH 1980 TO 1998
Author Reference Setting Study Period Definitions No. in Study
United States
Weinstein 14 Duke UMC, Robert Wood Feb 1992-Jan 1993 All positive blood cultures assessed. 1,585 episodes
Johnson UH, Salt Lake City Only patients >18 y included. 
VAMC Classified as HA according to CDC 
guidelines.73
Jarvis 15 NNIS hospitals Oct 1986-Dec 1990 CDC definitions.73 138,925 pathogens
Banerjee 4 124 NNIS hospitals Only 1989 data used CDC definitions.73 25,269 BSI 
(1980-1989)
Cockerill 16 Mayo Clinic Rochester, Nov 1984-Nov 1992 Two positive blood cultures required. 20,456 pathogens
microbiology laboratory
Pittet 6 University of Iowa Jul 1980-Jun 1992 All positive blood cultures assessed 3,461 HA BSIs
through prospective surveillance. 
HA 72 h after admission.
Roberts 17 Vancouver General Hospital, 1984-1987 One positive culture and clinical signs 1,244 episodes
Vancouver Clinic of the of infection.
British Columbia Cancer 
Agency
Morrison 3 State of Virginia 1978-1984 All positive blood cultures assessed 4,617 HA BSIs
through prospective surveillance. 
HA 48 h after admission.
Martin 18 University of Iowa Only 1980 included All positive blood cultures assessed NA
through prospective surveillance.
Stillman 19 University of Virginia 1975-1982 Clinical signs of infection + treatment 1,843 HA BSIs
for CNS. HA 48 h after admission.
Kirchhoff 20 University of Michigan Jan 1978-Feb 1980 Two positive blood cultures required. 4,733 isolates
Medical Center
Scheckler 5 Community hospital, St Mary’s 1970-1973, 1982, 1987 Two positive blood cultures required. 585 episodes
Hospital Medical Center
Weinstein 21 University of Colorado, Denver, Jul 1975-Mar 1977 All positive blood cultures assessed. 500 episodes
VAH HA 48 h after admission.
Europe
Jensen 22 Copenhagen county Oct 1992-Apr 1993 Each positive blood culture evaluated. 590 episodes
HA 48 h after admission.
Rubio 23 The Hospital University, San 1990-1992 Two positive blood cultures required. 2,166 BSIs
Carlos, Spain
Elhanan 25 University Hospital, Jan 1990-Jun 1991 Two positive blood cultures required. 1,048 cases
Tel-Aviv, Israel
(continued on page 585)
Abbreviations: BSI, bloodstream infection; CDC, Centers for Disease Control and Prevention; CNS, coagulase-negative staphylococci; HA, hospital-acquired infection; NA, not available; NNIS, National
Nosocomial Infection Surveillance System; UH, university hospital; UMC, university medical center; VA, Veteran’s Affairs; VAH, Veterans’ Affairs Hospital; VAMC, Veterans’ Affairs Medical Center.
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blood cultures. CNS bacteremia was defined as either one
positive blood culture plus a clinical picture compatible with
infection or as two positive blood cultures (Table 1).3-
7,9,10,14-35
Statistical Analysis
The sum of all BSIs (episodes), or of all bloodstream
isolates documented in each study period, was considered
for statistical analysis.6 Incidence rates per 1,000 discharges
or admissions were calculated. Linear trends were analyzed
using linear regression, with study years or the median year
of the study period considered as an independent variable
and numbers of BSI episodes or isolates, respectively, as
dependent variables. Statistical analysis was performed
using SPSS software (SPSS Inc, Chicago, IL).
RESULTS
Coagulase-negative staphylococci remain the most
important contaminants of blood cultures, accounting for
an average of 75% (range, 58%-85%) of all contaminated
blood cultures.9,10,14,17,22,24,36 The percentage of blood
cultures positive for CNS and representing true bacteremia
was very constant and similar both in time and numbers
between the United States and Europe (mean, 18%; range,
6%-31%).7,9,14,17,22,36,37
Global Trends
A global trend of increasing CNS bacteremia as a
proportion of all BSIs can be observed when combining all
hospitalwide studies retained for analysis (R=.51, Figure 1).
There is however a large spread, reflecting the heteroge-
TABLE 1 (continued)
STUDIES RETAINED FOR ANALYSIS OF TRENDED ESTIMATES, MEDLINE SEARCH 1980 TO 1998
Author Reference Setting Study Period Definitions No. in Study
Geerdes 7 University Hospital Klinikum, 1979, 1982, 1986, 1992 One positive blood culture for CNS 980 episodes
Steglitz in Berlinfour and criteria for septicemia.
HA 48 h after admission.
Arpi 10 Fredriksberg Hospital, UH, 1968-1992 Each positive blood culture evaluated. 
Copenhagen HA 72 h after admission. No pediatric 3,491 episodes
service.
Leibovici 26 Beilinson Medical Centre, Mar 1988-Sep 1990 Two positive blood cultures required 1,410 and 1,040 
Israel and St Thomas’s and 1987-1990 or 1 positive blood culture and 1 episodes
Hospital, London, UK positive blood culture from another 
source. HA 48 h after admission.
Maniatis 27 Dept. of Infectious Diseases, 1986-1994 Two positive blood cultures required. 993 isolates
Hellenic Air Force and VA 
General Hospital
Rosenthal 28 13 microbiology institutes in 1983-1985, Two positive blood cultures required. 12,880 episodes
Germany and Austria Aug 1991-Jul 1992
Haug 9 Bergen University Hospital, 1974-1979, 1988-1989 For CNS, at least two biochemically 648+799 episodes
Norway identical isolates.
HA 24 h after admission.
Dornbusch 29 37 laboratories in Europe 1987-1988 Isolates considered to be 3,440 isolates
contaminants were excluded.
French 30 Prince of Wales Hospital, May 1984-Jun 1989 Definitions of Weinstein et al.21 2,211 episodes
Hong Kong
Gatell 24 University of Barcelona, Spain Mar 1983-Feb 1986 All positive blood cultures evaluated. 1,366 episodes
HA 48 h after admission.
Vazquez 31 Hospital Covadonga of Oviedo, 1981-1984 Two positive blood cultures required. 43,63 episodes
Spain
Müller 32 University of Berlin, Germany 1979-1986 All positive blood cultures evaluated. 691 patients
Ispahani 33 University Hospital of 
Nottingham and three local Jan 1980-Dec 1983 Number of positive cultures and 933 episodes
hospitals clinical findings, but CNS regarded 
as highly improbable cause of infection.
Bruun 34 Statens seruminstitut, 1977-1978 Two positive blood cultures required. 3,170 isolates
Denmark
Michel 35 University Hospital Rotterdam, 1972-1977 Two positive blood cultures required. 1,289 BSIs
The Netherlands
Abbreviations: BSI, bloodstream infection; CDC, Centers for Disease Control and Prevention; CNS, coagulase-negative staphylococci; HA, hospital-acquired infection; NA, not available; NNIS, National
Nosocomial Infection Surveillance System; UH, university hospital; UMC, university medical center; VA, Veterans’ Affairs; VAH, Veterans’ Affairs Hospital; VAMC, Veterans’ Affairs Medical Center.
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neous hospital mix. Table 1 summarizes all the studies kept
for analysis.
Not only is the proportion of CNS increasing but also
the incidence of CNS bacteremia (Figure 2a; R=.54,
P=.0014). The analysis of incidence data was possible only
for teaching hospitals, this group being the most readily
compared.
Comparison of the United States Versus Europe
The incidence of nosocomial CNS BSIs increased
significantly in the United States over the study period
(R=.82, P=.0006; Figure 2b). In Europe, no significant trend
could be observed for nosocomial CNS bacteremias (R=.36,
P=.38) nor for the combined hospital- and community-
acquired CNS bacteremias (R=.44,
P=.075).9,22,24,25,33,35,36
The largest increase was reported from the Univer-
sity of Iowa Hospitals, with 0.97 episodes per 1,000 admis-
sions from 1981 to 1983, compared to 7.04 per 1,000 admis-
sions from 1990 to 1992.6 In the 1980s, the incidence of
nosocomial CNS bacteremia was reported to be higher in
the United States than in Europe, ranging from 0.26 to 7.04
episodes per 1,000 admissions in the United States3,6 and
from 0.15 to 1.16 in Europe.9,33 Between 1990 and 1992,
Rubio et al 23 reported an incidence of 4.23 episodes of
CNS bacteremia per 1,000 admissions in a Spanish univer-
sity hospital.
Community Hospitals
In the setting of community hospitals, only a few
studies were conducted, obviating any pooled trend analy-
sis. In the United States, Scheckler et al5 reported an
increase of CNS nosocomial bacteremia from 0.02 episodes
per 1,000 admissions from 1970 to 1973 to 0.47 in 1987
(1.2% and 16% of all BSI, respectively). In a community hos-
pital in Toronto,38 the proportion of BSIs due to CNS was
found to be 6.7% from 1980 to 1984.
In Europe, Iversen et al 8 reported the hospital-
acquired incidence in three local hospitals in northern Nor-
way to be 0.12 episodes per 1,000 admissions in 1985 and
1.05 in 1989 (4% and 28% of all BSIs, respectively). Similar
numbers were reported from a community hospital in
Israel in an 18-month prospective study from 1990 to
1991.25 The authors found an incidence of 1.13 nosocomial
episodes of CNS bacteremia per 1,000 admissions, repre-
senting 27% of all BSIs.
Intensive-Care Units
Generally, high incidence rates of CNS nosocomial
bacteremia are reported from ICUs worldwide,39,40 with a
mean of 8.76 episodes per 1,000 admissions in the studies
reviewed (range, 4.7-12.7; Table 2). In a National Nosoco-
mial Infection Surveillance (NNIS) System report from
1986 to 1997,41 CNS represented 33% of all primary BSIs in
ICUs. In a multicenter study from Spain, Valles et al42
reported CNS to represent 24% of BSIs in 1993. In another
study from Spain, 19% of BSIs were caused by CNS from
1988 to 1990.43
FIGURE 1. Proportion of all bloodstream infections caused by coagulase-
negative staphylococci, secular trend, 1970 to 1993. Hospitalwide 
studies, university and community hospitals.3-7,9,10,14,16-19,21-
31,33-35,74 Abbreviation: CNS, coagulase-negative staphylococci.
FIGURE 2. Trends in the overall incidence of coagulase-negative staphylo-
cocci (CNS) bacteremia.
FIGURE 2a. Hospitalwide studies from university hospitals.3,4,6,7,9,10,17-
25,31,33,35 Overall incidence of CNS bacteremia per 1,000 admissions (If
data only for nosocomial CNS bacteremia were available, this was used).
FIGURE 2b. CNS nosocomial bacteremia per 1,000 admissions in universi-
ty hospitals in the United States.3,4,6,18,19,51
https://doi.org/10.2307/30141785
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 13:46:25, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
Vol. 19  No. 8 INCREASING BACTEREMIA DUE TO CNS 585
Neonates
A high proportion of BSIs among neonates has been
attributed to CNS in recent years (mean, 33%; range, 3%-
78%; Table 2). They primarily are associated with late-onset
bacteremia and seen among neonates with very low birth
weight.1 Beck-Sague et al,44 from 1989 to 1991, and
Gaynes et al45 from 1989 to 1994, reported that 43% and
51%, respectively, of BSIs in high-risk nurseries are due to
CNS. In a study of very-low-birth-weight infants by Gray et
al,46 conducted from 1989 to 1990, 78% of all BSIs were
attributed to CNS.
In Europe, CNS bacteremia also has emerged in
recent years in neonatal ICUs. A striking increase was
described at St Thomas Hospital in London,47 where, in
the 1970s, only 3% of isolates were CNS; in the 1980s, 20%;
and in the 1990s, 44%. Källman et al37 in Örebro, Sweden,
found an increase from 15% from 1981 to 1987 to 24% from
1988 to 1994. Finally, at the Karolinska Hospital in Swe-
den,48 22% of all neonatal septicemia was attributed to CNS
in a prospective study from 1981 to 1985.
Number of Blood Cultures
In several longitudinal studies,5,8-10 a strong
increase over time has been noted in the number of blood
cultures performed per 1,000 admissions. The most strik-
ing increase was reported by Scheckler et al,5 from the
University of Wisconsin, where the number of blood cul-
tures increased sixfold from 1973 to 1987. In the few stud-
ies reporting the number of blood cultures, we could not
find a significant correlation between total CNS bacteremia
incidence and the number of blood cultures drawn (R=.30,
P=.28); however, a trend can be noted between incidence of
nosocomial CNS bacteremia and number of blood cultures
drawn (R=.59, P=.092; Figure 3). These numbers should be
interpreted with caution, as they are based on few stud-
ies,5,8-10,17,21,22,31,33,35,36,49 and complete data are not
given in all studies.
Mortality
The attributable mortality of CNS bacteremia is diffi-
cult to compare, as different methods were used to esti-
mate it. Most studies attribute death within 7 days of bac-
teremia to the infection if no other cause can be found; this
will be referred to as associated mortality.
Martin et al18 conducted a matched cohort study to
assess the attributable mortality of CNS bacteremia. In this
study, the mortality among the case-patients was 31%, com-
pared with 17% among matched controls; thus, the attribut-
able mortality was 14%. Apart from this study, all other
studies report associated mortalities. In the United States,
Weinstein et al14 reported an associated mortality of 5.5%,
and Roberts et al,17 using cumulative mortality, reported
5.3% mortality after 5 days, 16% after 30 days, and 25% at dis-
charge. Pittet et al50 reported 17% mortality after 28 days
and 29% at discharge. Importantly, nosocomial bacteremia
due to CNS was associated with a significantly lower risk of
death than other nosocomial bloodstream pathogens after
adjusting for other confounders.
FIGURE 3. Relation between obtaining blood cultures and incidence of coag-
ulase-negative staphylococci (CNS) bacteremia. Incidence of CNS nosoco-
mial bacteremia per 1,000 admissions versus number of blood cultures per-
formed per 1,000 admissions.5,9,22,33,35,36
TABLE 2
COAGULASE-NEGATIVE STAPHYLOCOCCAL BACTEREMIA: COMPARISON BETWEEN RATES IN HOSPITALWIDE SURVEYS AND SPECIAL-CARE UNITS
Hospitalwide Surveys Specific-Care Units
University Hospitals Community Hospitals Intensive-Care Units High-Risk Nurseries
Proportion* Incidence Proportion Incidence Proportion Incidence Proportion Incidence
Mean 11% 1.38 9% 0.74 26% 8.76 33% 2.18
Range 1.6%-30% 0.13-7.04 1 .7%-21% 0.09-1.46 19%-34% 4.7-12.7 3%-78% 0.34-6.90
Median 9% 0.80 6% 0.63 24% 8.88 24% 0.74
No. of studies 25 3 4 7
References 4, 6, 7, 9, 10, 14, 16-27, 5, 8, 25 41-43, 64 37, 44-48, 66
29-31, 33, 35, 74, 75
*Proportion refers to the percentage of all episodes of bloodstream infections due to coagulase-negative staphylococci. Incidence refers to episodes or isolates per 1,000 admissions.
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In Germany, Geerdes et al,7 using the definition of all
deaths within 30 days after the onset of septicemia, found
an associated mortality rate of 28% in 1979, which
decreased to 22% in 1989. In Spain, Fidalgo et al36 reported
an associated mortality of 19%, and Gatell et al24 found an
associated mortality of 11% (not specifying any time limits).
In Norway, the associated mortality was reported to be
4.9% from 1974 to 1979 and 5.9% from 1988 to 1989.9 Final-
ly, in the United Kingdom, the associated mortality was
reported to be 10% from 1980 to 1983.33
DISCUSSION
In this review, we confirm the increasing proportion
of BSIs due to CNS, compared to other pathogens, and the
overall increasing incidence of CNS bacteremias over the
past 2 decades. In addition, we observed increasing noso-
comial CNS bacteremias in the United States, whereas, in
Europe, no such trend could be found. An explanation of
this is the lack of data on incidence of nosocomial CNS bac-
teremia in Europe, with only six large studies from teach-
ing hospitals available, impeding meaningful comparisons.
It is also important to make a distinction concerning the
validity of studies between prospective hospital surveil-
lance data and laboratory data having little or no clinical
feedback. Most of the large studies in the United States
were based on prospective surveillance, whereas, in
Europe, the data often are based on laboratory reviews.
Therefore, an increasing trend of CNS bacteremia in
Europe cannot be ruled out on the basis of this review.
The greater heterogeneity in defining CNS bac-
teremia in Europe compared to the United States probably
explains in part the wide variation of results in Europe. In
the studies analyzed for an increase in incidence, 4 of 11
studies in Europe required at least two positive blood cul-
tures, whereas, in the United States, all investigators evalu-
ated each blood culture with reference to the clinical pic-
ture of the patient (Table 1). The differences in CNS distri-
bution between the different regions in Europe was
described by Dornbusch et al29 in the European Study
Group on Antibiotic Resistance. For unknown reasons, the
proportion of staphylococci other than Staphylococcus
aureus isolated from consecutively collected blood samples
ranged from 2% in Portugal to 28% in Switzerland.
For the observed increase of CNS bacteremia to be
validated,40 several hypotheses need to be investigated to
define potential biases or confounding factors. First, there
has been increased recognition and awareness of CNS
infections among clinicians due to the increased reporting
in recent years. CNS, has, in a relatively short period of
time, gone from being regarded as a harmless cutaneous
microorganism to being, in many studies, the most common
cause of bacteremia with a substantial related mortality.
Second, there has been a gradual change in the defi-
nition of bacteremia, from an obligatory two positive blood
cultures to one positive blood culture and a clinical picture
compatible with infection, as a result of several studies
demonstrating no difference in the positive predictive value
of one or two positive blood cultures.18,51-53 Although
Kirchhoff et al20 described in a retrospective study (1978-
1980), that the proportion of cultures positive for CNS is
much larger among true bacteremic patients (71%) than
among patients with contamination (34%), this may have
been influenced by their definition of true bacteremia,
which required at least two positive blood cultures. An
increased caution when judging one positive blood culture
allows for a more active approach to diagnosing CNS bac-
teremia; this possibly leads to increased reporting.
Third, there has been a change of blood culture prac-
tices and techniques. Sterilization of the venipuncture site,
the choice of venipuncture or drawing blood from an exist-
ing intravenous (IV) line, the inoculum volume, and the
medium used for culture all affect the sensitivity and speci-
ficity of blood cultures.40,54 It is not within the scope of
this review to compare each study’s techniques and prac-
tices, but it should be remembered as an important poten-
tial confounder. Pittet et al6 estimated that changing from
the BACTEC 460 (Johnston Laboratories, Towson, MD) to
the BACTEC 660 nonradiometric system and increasing
the inoculum from 5 mL to 10 mL enhanced the recovery
by 33%. That the inoculum volume is the most important
factor determining the sensitivity of blood cultures has
been shown by several studies, including that performed
by Mermel and Maki.55 In their study comparing normal-
volume to low-volume inoculum, the difference in yield was
23%. Furthermore, they reported that 88% of 158 US clinical
laboratories accepted blood cultures from adults containing
less than 5 mL. The conclusion is that a substantial number
of BSIs have gone undiagnosed. In the study by Weinstein
et al56 comparing 5-mL to 10-mL inoculum in the
BacT/Alert (Johnston Laboratories, Towson, MD) system
in 13,128 pairs of blood cultures, an overall increased yield
was found, but not a significantly larger yield for gram-
positive bacteria specifically.
Fourth, the importance of adjusting the incidence of
infection to the number of blood cultures performed was
shown by Haley et al in 1985.57 As mentioned before, sev-
eral longitudinal studies reported important increases in
the number of blood cultures performed. Although we did
not find a significant correlation between the incidence of
CNS bacteremia and the number of blood cultures per-
formed, there was a possible correlation between the inci-
dence of CNS nosocomial bacteremia and the number of
blood cultures. This finding suggests that both the number
of blood cultures performed and the technique used should
be taken into account when studying trends in BSIs. Impor-
tantly, this is advisable even for gram-negative bacteremia.
In our institution, the incidence of gram-negative bac-
teremia increased linearly (R=.90, P=.014), from 7.07 to 8.32
episodes per 1,000 admissions between 1989 and 1994,58
but this trend was no longer significant after adjustment for
the number of blood cultures drawn per year (R=.22,
P=.68).
Fifth, more severe underlying illnesses and an aging
population affect the incidence.5,40,59-62 The proportion
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of patients with ultimately or rapidly fatal underlying dis-
ease increased from 9% from 1974 to 1979 to 17% from 1988
to 1989 at Bergen University Hospital,9 affecting the rates
of BSI. In an NNIS System report from 1986 to 1990,63 54%
of nosocomial infections occurred in elderly patients (65
years and older).
Finally, CNS bacteremias are highly associated with
intravascular device use.7,14,18,22,24,26,36,42,43,45,51,64-
67 In a comparison between the former East and West Ger-
many, Rüden et al68 found a lower prevalence of nosoco-
mial infections in the former East German states, mainly
due to a lower use of devices. An estimated 5 million cen-
tral venous catheters are inserted into patients in the Unit-
ed States each year,69 but it is difficult to measure how
much the utilization of infusion IV devices has increased in
recent years. However, the increased use of intravascular
devices has been implicated in the increased rates of BSI
from 1979 to 1987 that were recorded by the National Hos-
pital Discharge Survey.70 Maki and Mermel 71 estimated
that more than 50% of all BSI episodes are associated with
intravascular devices. Of all catheter-associated infections,
CNS represent between 30% to 60%.72
There are several difficulties in making comparisons
between studies regarding CNS bacteremia. The first
major limitation is that the different authors present their
data in various ways and choose to focus on different rates
(prevalence, incidence, or incidence densities), risk factors,
and outcomes. Overall, this makes it difficult in many
instances to make appropriate comparisons. This is under-
scored by an NNIS System report by Jarvis et al in 1991,15
where the importance of the denominator is acknowl-
edged. This study demonstrates the need not only for
patient-related data but also for data related to device use
and length of hospitalization when making comparisons
between different units or hospitals. It has not been possi-
ble to compare these variables, as very few authors present
their data in this way. Only a few studies5,6,9,20,25report
incidence densities of BSI, which constitutes the most
appropriate way to study secular trends and adjust for con-
founders.
Second, different definitions are used to distinguish
between true BSI and the large number of contaminated
blood cultures. Obviously, the stringency in the judging of
positive blood cultures and the clinical state of the patient
affect the observed incidence. The main differences in
defining a true bacteremia stem from whether or not one
positive blood culture of two prompts evaluation of the sig-
nificance of this finding (Table 1). In many studies, these
episodes are excluded as contaminants per se. The justifi-
cation of the latter viewpoint is questionable, considering
that several studies have shown little difference in the pos-
itive predictive value of one-of-two or two-of-two positive
blood cultures.18,51-53
Finally, the heterogeneity of the patient populations
and their varying susceptibility to infection influences the
rates and outcomes reported. For the purpose of this
review, the studies were stratified into four categories, with
a focus on large tertiary-care centers. For community hos-
pitals, ICUs, and high-risk nurseries, only a brief review
was done to show the differences between different hospi-
tals and wards (Table 2). However, it should be noted that
most studies from teaching hospitals include several ICUs,
high-risk nurseries, and oncology clinics. As these units
have the highest incidences reported, it is clear that the
hospitalwide incidence depends largely on their profile. For
example, some studies report data based only on adults,
hence removing the effect of neonates on the reported
rates. Thus, to make a comparison and an overview of
trends possible, the assumption was made that tertiary-
care referral centers have an approximately similar case
mix and severity of illness in their patient populations.
CONCLUSIONS
In summary, there is an overall increasing trend of
true CNS bacteremia, both measured as a proportion of
BSI and as an incidence. Furthermore, there is a trend of
increasing nosocomial CNS bacteremias in the United
States, whereas no trend could be found in Europe. Possi-
ble explanations for this are a lack of studies reporting data
on CNS nosocomial bacteremia in Europe, regional differ-
ences in Europe regarding rates, and a less uniform defini-
tion of CNS bacteremia in Europe. The reasons for the
regional differences in Europe could be several; specula-
tive explanations include IV-device use, blood culture prac-
tices, and heterogeneous methods for surveillance and def-
initions of infections.
The influence of the number of blood cultures per-
formed is difficult to determine, as we found partly contra-
dicting results. It can only be recommended that, in future
epidemiological studies, rates be reported as incidence
densities, number of blood cultures be assessed, and rates
be adjusted for this variable to exclude a potential bias.
Finally, it can be concluded that CNS bacteremia is a reali-
ty and an important cause of bacteremia, with a morbidity
and a mortality that cannot be ignored. A significant pro-
portion of CNS bacteremia should be avoided by preven-
tion of device-associated nosocomial infections, making
explanatory epidemiology of the disease useful to the
patient.
REFERENCES
1. Boyce JM. Coagulase-negative staphylococci. In Mayhall G, ed. Hospital
Epidemiology and Infection Control; Baltimore, MD: Williams & Wilkins;
1996:306-325.
2. McGowan JE Jr. Changing etiology of nosocomial bacteremia and
fungemia and other hospital-acquired infections. Rev Infect Dis
1985;7(suppl 3):S357-S370.
3. Morrison AJ Jr, Freer CV, Searcy MA, Landry SM, Wenzel RP. Nosoco-
mial bloodstream infections: secular trends in a statewide surveillance
program in Virginia. Infect Control 1986;7:550-553.
4. Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan TC,
et al. Secular trends in nosocomial primary bloodstream infections in
the United States, 1980-1989. National Nosocomial Infections Surveil-
lance System. Am J Med 1991;91:86S-89S.
5. Scheckler WE, Scheibel W, Kresge D. Temporal trends in septicemia in
a community hospital. Am J Med 1991;91:90S-94S.
6. Pittet D, Wenzel RP. Nosocomial bloodstream infections: secular trends
in rates, mortality, and contribution to total hospital deaths. Arch Intern
Med 1995;155:1177-1184.
https://doi.org/10.2307/30141785
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 13:46:25, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
588 INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY August 1998
7. Geerdes HF, Ziegler D, Lode H, Hund M, Loehr A, Fangmann W, et al.
Septicemia in 980 patients at a university hospital in Berlin: prospective
studies during 4 selected years between 1979 and 1989. Clin Infect Dis
1992;15:991-1002.
8. Iversen G, Scheel O. Epidemiological aspects of community-acquired
and hospital-acquired bacteremia in northern Norway. Scand J Infect Dis
1993;25:465-470.
9. Haug JB, Harthug S, Kalager T, Digranes A, Solberg CO. Bloodstream
infections at a Norwegian university hospital, 1974-1979 and 1988-1989:
changing etiology, clinical features, and outcome. Clin Infect Dis
1994;19:246-256.
10. Arpi M, Renneberg J, Andersen HK, Nielsen B, Larsen SO. Bacteremia
at a Danish university hospital during a twenty-five-year period (1968-
1992). Scand J Infect Dis 1995;27:245-251.
11. Eykyn SJ, Gransden WR, Phillips I. The causative organisms of septi-
caemia and their epidemiology. J Antimicrob Chemother 1990;25(suppl
C):41-58.
12. Rupp ME, Archer GL. Coagulase-negative staphylococci: pathogens
associated with medical progress. Clin Infect Dis 1994;19:231-245.
13. Lew DP, Pittet D, Waldvogel FA. Infections that complicate the insertion
of prosthetic devices. In: Mayhall G, ed. Hospital Epidemiology and Infec-
tion Control; Baltimore, MD: Williams & Wilklins; 1995:731-748.
14. Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmi-
giani G, et al. The clinical significance of positive blood cultures in the
1990s: a prospective comprehensive evaluation of the microbiology, epi-
demiology, and outcome of bacteremia and fungemia in adults. Clin
Infect Dis 1997;24:584-602.
15. Jarvis WR, Edwards JR, Culver DH, Hughes JM, Horan T, Emori TG, et
al. Nosocomial infection rates in adult and pediatric intensive care units
in the United States. National Nosocomial Infections Surveillance Sys-
tem. Am J Med 1991;91:185S-191S.
16. Cockerill FR, Hughes JG, Vetter EA, Mueller RA, Weaver AL, Ilstrup
DM, et al. Analysis of 281,797 consecutive blood cultures performed
over an eight-year period: trends in microorganisms isolated and the
value of anaerobic culture of blood. Clin Infect Dis 1997;24:403-418.
17. Roberts FJ, Geere IW, Coldman A. A three-year study of positive blood
cultures, with emphasis on prognosis. Rev Infect Dis 1991;13:34-46.
18. Martin MA, Pfaller MA, Wenzel RP. Coagulase-negative staphylococcal
bacteremia. Mortality and hospital stay. Ann Intern Med 1989;110:9-16.
19. Stillman RI, Wenzel RP, Donowitz LC. Emergence of coagulase negative
staphylococci as major nosocomial bloodstream pathogens. Infect Con-
trol 1987;8:108-112.
20. Kirchhoff LV, Sheagren JN. Epidemiology and clinical significance of
blood cultures positive for coagulase-negative staphylococcus. Infect
Control 1985;6:479-486.
21. Weinstein MP, Reller LB, Murphy JR, Lichtenstein KA. The clinical sig-
nificance of positive blood cultures: a comprehensive analysis of 500
episodes of bacteremia and fungemia in adults, I: laboratory and epi-
demiologic observations. Rev Infect Dis 1983;5:35-53.
22. Jensen AG, Kirstein A, Jensen I, Scheibel J, Espersen F. A 6-month
prospective study of hospital-acquired bacteremia in Copenhagen coun-
ty. Scand J Infect Dis 1996;28:601-608.
23. Rubio M, Palau L, Vivas JR, del Potro E, Diaz Mediavilla J, Alvarez A, et
al. Predominance of gram-positive microorganisms as a cause of sep-
ticemia in patients with hematological malignancies. Infect Control Hosp
Epidemiol 1994;15:101-104.
24. Gatell JM, Trilla A, Latorre X, Almela M, Mensa J, Moreno A, et al.
Nosocomial bacteremia in a large Spanish teaching hospital: analysis of
factors influencing prognosis. Rev Infect Dis 1988;10:203-210.
25. Elhanan G, Raz R, Pitlik SD, Sharir R, Konisberger H, Samra Z, et al.
Bacteraemia in a community and a university hospital. J Antimicrob
Chemother 1995;36:681-695.
26. Leibovici L, Gransden WR, Eykyn SJ, Konisberger H, Drucker M, Pitlik
SD, et al. Clinical index to predict bacteraemia caused by staphylococci.
J Intern Med 1993;234:83-89.
27. Maniatis AN, Trougakos IP, Katsanis G, Palermos J, Maniatis NA,
Legakis NJ. Changing patterns of bacterial nosocomial infections: a
nine-year study in a general hospital. Chemotherapy 1997;43:69-76.
28. Rosenthal EJ. The epidemiology of septicemia causative agents. A blood
culture study of the Paul Ehrlich Society for Chemotherapy. Dtsch Med
Wochenschr 1993;118:1269-1275.
29. Dornbusch K, the European Study Group on Antibiotic Resistance.
Resistance to b-lactam antibiotics and ciprofloxacin in gram-negative
bacilli and staphylococci isolated from blood: a European collaborative
study. J Antimicrob Chemother 1990;26:269-278.
30. French GL, Cheng AF, Duthie R, Cockram CS. Septicaemia in Hong
Kong. J Antimicrob Chemother 1990;25(suppl C):115-125.
31. Vazquez F, Mendoza MC, Villar MH, Perez F, Mendez FJ. Survey of bac-
teraemia in a Spanish hospital over a decade (1981-1990). J Hosp Infect
1994;26:111-121.
32. Müller F, Hund M, Lohr J, Lode H, Wagner J, Fangmann W. Infection
1979 to 1986. Epidemiology, etiology, clinical aspects and prognosis in
691 patients. Med Klin 1989;84:323-328.
33. Ispahani P, Pearson NJ, Greenwood D. An analysis of community and
hospital-acquired bacteraemia in a large teaching hospital in the United
Kingdom. QJM 1987;63:427-440.
34. Bruun B, Sloth K, Bentzon MW, Frederiksen W. A study of bacteremias
in Denmark from 1977-1978. APMIS [B] 1982;90:309-317.
35. Michel MF, Priem CC. Positive blood cultures in a university hospital in
the Netherlands. Infection 1981;9:283-289.
36. Fidalgo S, Vazquez F, Mendoza MC, Përez F, Mëndez FJ. Bacteremia
due to Staphylococcus epidermidis: microbiologic, epidemiologic, clinical,
and prognostic features. Rev Infect Dis 1990;12:520-528.
37. Källman J, Kihlström E, Sjöberg L, Schollin J. Increase of staphylococci
in neonatal septicaemia: a fourteen-year study. Acta Paediatr
1997;86:533-538.
38. Righter J. Septicemia due to coagulase-negative Staphylococcus in a com-
munity hospital. Can Med Assoc J 1987;137:121-125.
39. Pittet D, Harbarth S. The intensive care unit. In: Bennett JV, Brachman
PS, eds. Hospital Infections. Boston, MA: Little, Brown and Co; 1998:381-
402.
40. Pittet D. Nosocomial bloodstream infections. In Wenzel RP, ed. Preven-
tion and Control of Nosocomial Infections. Baltimore, MD: Williams &
Wilkins; 1997:712-769.
41. Hospital Infection Program, Centers for Disease Control and Preven-
tion, Public Health Service; US Department of Health and Human Ser-
vices. National Nosocomial Infections Surveillance (NNIS) System
report, data summary from October 1986-April 1997. Am J Infect Control
1997;25:477-487.
42. Valles J, Leon C, Alvarez-Lerma F. Nosocomial bacteremia in critically ill
patients: a multicenter study evaluating epidemiology and prognosis.
Spanish collaborative group for infections in intensive care units. Clin
Infect Dis 1997;24:387-395.
43. Rello J, Ricart M, Mirelis B, Quintana E, Gurgui M, Net A, et al. Noso-
comial bacteremia in a medical-surgical intensive care unit: epidemio-
logic characteristics and factors influencing mortality in 111 episodes.
Intensive Care Med 1994;20:94-98.
44. Beck-Sague CM, Azimi P, Fonseca SN, Baltimore RS, Powell DA, Bland
LA, et al. Bloodstream infections in neonatal intensive care unit patients:
results of a multicenter study. Pediatr Infect Dis J 1994;13:1110-1116.
45. Gaynes RP, Edwards JR, Jarvis WR, Culver DH, Tolson JS, Martone WJ.
Nosocomial infections among neonates in high-risk nurseries in the
United States. National Nosocomial Infections Surveillance System.
Pediatrics 1996;98:357-361.
46. Gray JE, Richardson DK, McCormick MC, Goldmann DA. Coagulase-
negative staphylococcal bacteremia among very low birth weight
infants: relation to admission illness severity, resource use, and out-
come. Pediatrics 1995;95:225-230.
47. Gransden WR, Eykyn SJ, Phillips I. Septicaemia in the newborn and
elderly. J Antimicrob Chemother 1994;34(suppl A):101-119.
48. Faxelius G, Ringertz S. Neonatal septicemia in Stockholm. Eur J Clin
Microbiol Infect Dis 1987;6:262-265.
49. Ljungman P, Malmborg AS, Nyström B, Tillegard A. Bacteremia in a
Swedish university hospital: a one-year prospective study in 1981 and a
comparison with 1975-76. Infection 1984;12:243-247.
50. Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influenc-
ing the outcome of nosocomial bloodstream infections. A six year vali-
dated, population-based model. Clin Infect Dis 1997;24:1068-1078.
51. Ponce de Leon S, Wenzel RP. Hospital-acquired bloodstream infections
with Staphylococcus epidermidis. Am J Med 1984;77:639-644.
52. Herwaldt LA, Geiss M, Kao C, Pfaller MA. The positive predictive value
of isolating coagulase-negative staphylococci from blood cultures. Clin
Infect Dis 1996;22:14-20.
53. Dominguez-de Villota E, Algora-Weber A, Millian I, Rubio JJ, Galdos P,
Mosquera JM. Early evaluation of coagulase negative staphylococcus in
blood samples of intensive care unit patients. A clinically uncertain
judgement. Intensive Care Med 1987;13:390-394.
54. Chandrasekar PH, Brown WJ. Clinical issues of blood cultures. Arch
Intern Med 1994;154:841-849.
55. Mermel LA, Maki DG: Detection of bacteremia in adults: consequences
of culturing an inadequate volume of blood. Ann Intern Med
1993;119:270-272.
56. Weinstein MP, Mirrett S, Wilson ML, Reimer LG, Reller LB. Controlled
evaluation of 5 versus 10 milliliters of blood cultured in aerobic
bact/alert blood culture bottles. J Clin Microbiol 1994;32:2103-2106.
57. Haley RW, Culver DH, Morgan WM, White JW, Emori TG, Hooton TM.
Increased recognition of infectious diseases in US hospitals through
increased use of diagnostic tests, 1970-1976. Am J Epidemiol
1985;121:168-181.
58. Harbarth S, Rohner P, Auckenthaler R, Safran E, Sudre P, Pittet D. Gram-
negative bacteremia: Incidence, antimicrobial resistance and impact at a
large teaching hospital. The Eighth Society for Healthcare Epidemiolo-
gy Annual Meeting; Orlando, FL; April 5, 1998. Abstract 25.
59. Pittet D, Thiévent B, Wenzel RP, Li N, Gurman G, Suter PM. Importance
of pre-existing co-morbidities for prognosis of septicemia in critically ill
patients. Intensive Care Med 1993;19:265-272.
60. Leibovici L, Pitlik SD, Konisberger H, Drucker M. Bloodstream infec-
tions in patients older than eighty years. Age Ageing 1993;22:431-442.
61. Perl TM, Dvorak L, Hwang T, Wenzel RP. Long-term survival and func-
tion after suspected gram-negative sepsis. JAMA 1995;274:338-345.
62. Olhsson K, Bjsrk P, Bergenfeldt M, Hageman R, Thompson RC. Inter-
leukin-1 receptor antagonist reduces mortality from endotoxin shock.
https://doi.org/10.2307/30141785
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 13:46:25, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
Vol. 19  No. 8 INCREASING BACTEREMIA DUE TO CNS 589
Nature 1990;348:550-552.
63. Emori TG, Banerjee SN, Culver DH, Gaynes RP, Horan TC, Edwards JR,
et al. Nosocomial infections in elderly patients in the United States, 1986-
1990. National Nosocomial Infections Surveillance System. Am J Med
1991;91:289S-293S.
64. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in crit-
ically ill patients: excess length of stay, extra costs, and attributable mor-
tality. JAMA 1994;271:1598-1601.
65. Hirakata Y, Furuya N, Iwata M, Kashitani F, Ishikawa M, Yumoto S, et
al. Assessment of clinical significance of positive blood cultures of rela-
tively low-virulence isolates. J Med Microbiol 1996;44:195-198.
66. Nataro JP, Corcoran L, Zirin S, Swink S, Taichman N, Goin J, et al.
Prospective analysis of coagulase-negative staphylococcal infection in
hospitalized infants. J Pediatr 1994;125:798-804.
67. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin
M-H, et al. The prevalence of nosocomial infection in intensive care units
in Europe. Results of the European Prevalence of Infection in Intensive
Care (EPIC) Study. JAMA 1995;274:639-644.
68. Rüden H, Gastmeier P, Daschner F, Schumacher M. Nosocomial infec-
tions in Germany. Their epidemiology in old and new Federal Länder.
Dtsch Med Wochenschr 1996;121:1281-1287.
69. Raad I, Darouiche R. Prevention of infections associated with intravas-
cular devices. Current Opinion in Critical Care 1996;2:361-365.
70. Centers for Disease Control. Increase in national hospital discharge sur-
vey rates for septicemia—United States, 1979-1987. MMWR 1990;39:31-
34.
71. Maki DG, Mermel LA. Infections due to infusion therapy. In: Bennett JV,
Brachman PS, eds. Hospital Infections. Philadelphia, PA: Lippincott-
Raven; 1998:689-724.
72. Widmer AF: Intravenous-related infections. In: Wenzel RP, ed. Preven-
tion and Control of Nosocomial Infections. Baltimore, MD: Williams &
Wilkins; 1997:771-805.
73. Garner JS, Jarvis WR, Emori TG, Toran TC, Hughes JM. CDC defini-
tions for nosocomial infections. Am J Infect Control 1988;16:128-140.
74. Jarvis WR, Martone WJ. Predominant pathogens in hospital infections.
J Antimicrob Chemother 1992;29(suppl A):19-24.
75. Sage R, Nazareth B, Noone P. A prospective randomised comparison of
cefotaxime vs. netilmicin vs. cefotaxime plus netilmicin in the treatment
of hospitalised patients with serious sepsis. Scand J Infect Dis
1987;19:331-337.
Gina Pugliese, RN, MS
Martin S. Favero,PhD
The fluoroquinolones ciprofloxacin
and ofloxacin are among the antimicro-
bials recommended for treating uncompli-
cated gonorrhea. Fluoroquinolone-resis-
tant strains of Neisseria gonorrhoeae have
been identified frequently in the 1990s in
the Far East. In the United States, fluoro-
quinolone-resistant N gonorrhoeae has
been reported previously in only one per-
son, who probably acquired the infection
in the Philippines.
The CDC recently reported two
cases of gonococcal infection in San Diego
involving strains with a higher level of flu-
oroquinolone resistance than reported
previously; there was clinical treatment
failure in one case.
Because fluoroquinolone-resistant N
gonorrhoeae is rare in the United States,
the CDC recommends fluoroquinolones to
treat gonococcal infections. However, cef-
triaxone, cefixime, or spectinomycin
should be used if the infection was
acquired in Asia. In some areas of the Unit-
ed States, (eg, Cleveland, Ohio) where
strains with decreased susceptibility to flu-
oroquinolones are endemic, fluoro-
quinolones should not be used to treat
gonococcal infections, because these
strains may represent a pool from which
fluoroquinolone-resistant strains may
emerge. Laboratories serving patients
with gonococcal infections should main-
tain culture capabilities to evaluate
patients with apparent treatment failures.
Laboratories should report any isolate
meeting proposed National Committee for
Clinical Laboratory Standards criteria for
resistance to ciprofloxacin (minimum
inhibitory concentration [MIC] >1.0
µg/mL; zone inhibition diameter [5 µg
disk] <27 mm) or ofloxacin (MIC >2.0
µg/mL; zone inhibition diameter [5 µg
disk] <24 mm) to their state public health
laboratory; CDC laboratories will confirm
resistant isolates.
FROM: Fluoroquinolone-resistant
Neisseria gonorrhoeae—San Diego, Cali-
fornia, 1997. MMWR 1998;47:405-408.
Fluoroquinolone-Resistant Neisseria gonorrhoeae
On April 28, 1997, the Valencia
Health Department in Spain announced
that 217 people who had surgery within
the past year in two Valencian hospitals
have been infected with hepatitis C virus
(HCV). The source of the HCV infection
was an anesthetist who had been working
at the hospitals for the past 5 years. 
The anesthetist, a morphine addict
for many years, has the same HCV
genome as the infected patients. It was
reported that, in the immediate postopera-
tive period, just before he gave intra-
venous opioid analgesia to patients, he
gave himself part of the syringe contents
and then gave the remainder to the patient
via the same syringe. He had been obliged
to retire from a post at another Valencian
hospital when it became known that he
had falsified signatures to obtain opioids
from the pharmacy.
Health Department chief Joaquín
Farnós said that more than 2,000 patients
will be screened for HCV in the next few
weeks. The results of the outbreak investi-
gation, which may take approximately 3
months to complete, then will be sent to
the appropriate court to decide legal
action. The Health Department already
has started disciplinary proceedings
against seven of the anesthetist’s col-
leagues for an apparent “silence pact,”
because none raised the alarm despite
knowledge of these activities.
FROM: Bosch X. Hepatitis C out-
break astounds Spain. Lancet 1998;
351:1415.
Anesthetist Transmits Hepatitis C 
to 217 Patients
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